Psychedelic therapy has been gaining not only popularity but acceptance in the medical community in recent years.
Articles
Virginia Conference Committee Faces Saturday Deadline To Finalize Marijuana Legalization Proposal
Virginia lawmakers are working to reconcile conflicting House and Senate marijuana legalization bills this week, scrambling to reach deals on matters such as business licensing and criminal penalties ahead of a legislative deadline on Saturday.
Psychedelic Drug Stocks Then-And-Now: Six Months Ago Versus Today
Psychedelic stocks are well off of their 2020 highs. But they are even further from their 2020 lows. Opportunity knocks.
Massachusetts Moves Forward In Decriminalizing Psychedelics
Massachusetts lawmakers are moving forward to decriminalize psychedelic drugs. T
NYU launching $10M Center for Psychedelic Medicine in Manhattan
New York University wants to expand our minds — but in a trippy new way.
Microneedle patches for microdosing psychedelic pharmaceuticals
Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive results when testing them for medical use.
Proposed California Psychedelics Bill Would Be Sector Turning Point
California's new proposed psychedelics "decriminalization" would, in fact, LEGALIZE possession of many psychedelic substances.
Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors
MINDCURE's new Director is a veteran of capital markets.
Why Is Everyone So Obsessed With Mushrooms Right Now?
It used to be that the only time I really saw mushrooms was when a few white button mushrooms appeared on a garden salad or atop my cheese pizza.
New Jersey Gov. Signs Bill to Legalize Cannabis
After over three months since voters approved the state’s cannabis legalization ballot question, New Jersey Gov. Phil Murphy (D) today signed into law a series of bills that ultimately legalize the adult use of cannabis.
MINDCURE’s Psychedelics R&D Targets Blockbuster TBI Treatment Market
MINDCURE's R&D on traumatic brain injury (TBI) targets the LARGEST individual market for psychedelic drugs.
Mindset Pharma Added to North American Psychedelics Index
Toronto, Ontario-- Mindset Pharma Inc., a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce that effective today, it has been added to the North American Psychedelics Index which is provided by German-based index provider, Solactive.
Vermont Lawmakers Prepare Psychedelics And Broader Drug Decriminalization Bills For Introduction
Vermont lawmakers plan to introduce at least two bills this legislative session to decriminalize the possession of drugs, with one of those proposals expected early next week.
New Study Suggests Link Between Cannabis Legalization And Decline In Workers Comp Claims
A new research paper from the National Bureau of Economic Research suggests a connection between marijuana legalization and a decline in workers’ compensation claims.
MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company
MindMed enhances its mental health platform with the acquisition of a machine-learning digital medicine company.